Toong-Hua LIANG, “Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial”, Archives of Rheumatology, vol. 35, no. 2, pp. 170–179, Jun. 2020.